Disclaimer - Nothing on this blog is intended as investing or financial advice. Please do your own due diligence.
In this short post I’ll talk about 5 of my current value investments and explain shortly why I invested in them, my average cost per share, and share a longer analysis I’ve read on them. While these are some of my value plays these aren’t all of my investments. I have some investments that I do consider value plays but they are mega caps like $META ( at a share price of $215) which have tons of theses on it and don’t need my take on it. There are also investments that I’m still working on that I won’t mention in this post.
1 - QRHC
My Average Share Price - $7.02
QRHC is a asset light waste and recycling company that gets big companies as clients ( for example some of their clients include Buffalo Wild Wings, John Deere, and Kroger) and works with independent waste haulers to service all of a companies locations. This writeup from value investors club gives a great thesis on the upside in QRHC.
The writeup was written in late June last year and has since performed quite well. Most recently their gross profit is growing at double digit rates and have had more client wins in the past 6 months than they’ve had in years. I’m still incredibly bullish on this company and highly recommend everyone to read the writeup.
2 - HROW
My Average Share Price - $11.80
Harrow is an eyecare pharmaceutical company that has a couple of great products that are already FDA approved. Mark Baum the CEO founded the company and has helped them grow over the years. He has a bold plan to reach $1 billion in revenue by 2027 using what he calls the 5 buckets. The two biggest things to make this possible are IHEEZO and VEYVE which are two of their products that have been released recently and are starting to ramp up.
An incredible write up on HROW is this one that I would highly recommend reading to learn more in depth about this idea.
3 - VBNK
My Average Share Price - $10.15
VersaBank is a Canadian microcap bank that has 2 catalyst and is trading below 1x P/B. I recently wrote a stock analysis on VersaBank where I discuss the bank.
(Before I was able to post this their acquisition was finalized and the shares are now up 15%.)
4 - NU
My Average share price - $ 7.70
Nubank is a digital bank that started in Brazil and is now growing to Mexico, Colombia, Germany, etc. They have been growing incredibly quickly while having incredibly good margins and statistics. Over 92 million people in Brazil have an account with NU.
Kairos research wrote this great writeup on NU where he explains NU’s business model, it’s background, their future plans, and areas for growth.
5 - CRMT
My Average share price - $ 57.75
Car-mart is a buy here pay here used car dealership that has 154 dealerships in 12 different states. This is by far the riskiest of the 5 companies and it’s my smallest position.
Car-mart currently has $1.08 billion in accounts receivable which equals to about 169$ in receivables per share while the shares are trading at $63. This doesn’t include the AR that Car-mart has set aside for losses which in total equals $1.4 billion. they currently have 1.4 billion in total assets and $ 921 million in total liabilities.
While the AR per share looks incredibly attractive this business sector as a whole is in the worst condition it’s been in years. With interest rates being higher Car-mart’s customers are struggling to pay their loans. To try to counteract this Car-mart has started increasing the terms on their loans which isn’t good for the business as they receive the same amount of money as before just over a longer time frame.
I haven’t found any recent write ups on Car-mart but Geoff Gannon has talked about them on his podcast (Focused Compounding) a bit and wrote a bit about them on his website ( also Focused Compounding). If you are thinking about investing in a company like this I highly recommend you do a lot of research as it’s a very risky investment.
I found a short thesis on harrow here
https://www.bonitasresearch.com/company/short-harrow-health-hrow/
Have you considered the points he makes? If it is a good investment, the short thesis should be disproven IMO. Cheers
Hi, I've written three articles on HROW on my blog. I must say the last two are of far better quality than the first one, which takes too much pain at spotting fraud everywhere. You might want to take a look at them.